Cell & Developmental Biology
Open Access

Jesus Canudas

Biography

Jesus Canudas working at Araclon Biotech Ltd., Hispanidad 21, 50009 Zaragoza, Spain. Jesus Canudas recent publication is “Safety, tolerability and immunogenicity of an active anti-Aβ 40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial” and has international experience on various programs, and also contributed and participated in different countries for diverse fields of study. Research interests reflect in wide range of publications in various national and international journals.

Research Interest

Developmental Biology, Central Nervous System

Relevant Topics